FDA
FDA approves first presbyopia eye drop
US regulators have approved the country’s first presbyopia eye drop that adopts pupil constriction to improve near and intermediate vision ...
Glaukos pens new deal for Preserflo MicroShunt
Glaukos has signed a new license agreement with Santen Pharmaceutical for the Preserflo MicroShunt, obtaining exclusive rights for the therapy ...
New iTrack trial comparing efficacy and safety ab-interno canaloplasty
Nova Eye Medical has announced eight surgery centres across the US have commenced a prospective, randomised clinical trial to assess ...
Cornea transplant policy out-of-step with current evidence
A US Food and Drug Administration (FDA) policy that automatically disqualifies men who have had sex with men in the ...
US approves first ever treatment for thyroid eye disease
Horizon Therapeutics has had its drug Tepezza, which is the first ever treatment for thyroid eye disease, approved by The ...
CooperVision’s MiSight receives FDA approval, to launch in 2020
CooperVision has received clearance from the US Food and Drug Administration (FDA) for its MiSight 1 Day Contact Lens for ...
FDA clears Novartis’ new treatment for nAMD
Novartis has secured US regulatory approval for Beovu, the company’s latest therapy for neovascular age-related macular degeneration (nAMD), following the ...